Advertisement
Supply Chain
Subscribe to Supply Chain

The Lead

UPS Survey: Time to Act on Untapped Opportunites in Healthcare Industry

September 23, 2014 2:48 pm | News | Comments

An environment of increasing risks, complex regulations and continuing cost pressures is impeding healthcare executives from moving quickly to seize untapped industry opportunities, according to the 7th annual UPS "Pain in the (Supply) Chain" survey.

The Future of Chemicals: Managing Complexity and Enabling Growth with Natural Supply Chains

September 16, 2014 8:45 am | by Rohit Singh, Principal, Strategy; and Marc Waco, Partner, PwC US Chemicals Advisory Leader | Blogs | Comments

In an increasingly complex and challenging climate, chemical companies are facing a combination...

Surveying The Industry’s Needs

December 4, 2013 9:35 am | by Mike Auerbach, Editor in Chief | Articles | Comments

Our annual reader survey looks at issues facing innovator companies and the CMO/CSOs that...

Best Practices in Demand and Inventory Planning for Pharmaceutical Companies

September 13, 2013 9:06 am | by Aptean | White Papers

Supply chain planning involves functions such as demand forecasting and planning, distribution...

View Sample

FREE Email Newsletter

Transparency in the Supply Chain

April 10, 2013 1:29 pm | by Mike Rozembajgier | Articles | Comments

An increase in the number of Internet pharmacies distributing pharmaceuticals to consumers online and heightened public scrutiny have led authorities to pay close attention to the issue of counterfeit medications. And already this year, the U.S. Food and Drug Administration (FDA) has issued a health care provider alert warning about an unapproved, counterfeit cancer medication that was distributed in the U.S.

DSM Signs Master Supply Agreement with Eisai Inc.

March 5, 2013 8:00 am | News | Comments

DSM Pharmaceutical Products, the custom manufacturing and technology business of Royal DSM, today announced the signing of a 3 year master supply agreement with Eisai Inc., based in Woodcliff Lake, NJ, USA, for the production of sterile products.  The agreement covers the production of eribulin mesylate as well as other developmental drugs.

Tris Pharma Expands Manufacturing Capacity and Strengthens Supply Chain to Support New and Pending Approvals

July 11, 2012 4:02 am | News | Comments

Tris Pharma, a specialty pharmaceutical company with fully integrated commercial manufacturing and drug development operations, announced today that in order to meet demand for its products (approved and near term) the company has fortified its supply chain, increased manufacturing capacity and strengthened its management team.  

Advertisement

ValueTrak Safe & Secure Supply Chain Module Wins 2011 HDMA Distribution Management Award

March 8, 2011 8:17 am | by The Associated Press | News | Comments

Today, ValueCentric was awarded the 2011 HDMA Distribution Management Award for their newest ValueTrak module, Safe & Secure Supply Chain. This award highlights new innovative business processes and the latest best practices in technology that improve the...

Report: Pharmaceutical Supply Chains Are Due for a Radical Overhaul

February 22, 2011 3:50 am | News | Comments

While recent attention has focused on issues such as the challenges associated with drug discovery and the regulatory review process, pharmaceutical companies have invested comparatively little effort in updating their manufacturing and distribution operations, many of which are inefficient, under-utilized and ill-equipped to cope with new medicines, cost pressures and health reform expectations

Keeping the Supply Chain Pure: New Coating Technologies Contain Information to Authenticate Solid Oral Dose Pharmaceuticals

May 7, 2010 10:08 am | by John D’Ottavio, Quality and Regulatory Affairs Manager, ARmark Authentication Technologies, LLC; and MaryAnn Hegedus, Business Development Manager, Colorcon, Inc. | Articles | Comments

A draft guidance recently issued by the Food and Drug Administration 1   provides specific recommendations for pharmaceutical manufacturers on the use of inks, pigments, flavors, and other molecular taggants used as physical-chemical identifiers (PCIDs) in immediate release film coatings for anticounterfeiting measures.

Advisory Firm Selected To Analyze China Pharma Supply Chain On U.S Pharmaceuticals

May 20, 2009 11:13 am | News | Comments

NSD Bio Group, LLC - North American Advisory firm, has been tapped by the U.S. China Economic and Security Review Commission, to conduct special research and analyses on the increasing role of China's raw ingredients used in pharmaceutical products and dietary supplements manufactured and sold in the U.S. marketplace.

Security and RFID's Place in the Pharmaceutical Supply Chain

May 11, 2009 10:13 am | Articles | Comments

At INTERPHEX, in March 2009, an expert panel convened to discuss the challenges facing the pharmaceutical industry in meeting the FDA's guidance regarding e-pedigree, and to address the larger global issues surrounding the implementation of RFID as part of a secure supply chain solution.

The Track and Trace Challenge of the Global Pharmaceutical Supply Chain

June 2, 2008 7:18 am | Pharmaceutical Processing | Product Releases | Comments

The pharmaceutical industry’s supply chain has become the focus of daily headlines, and often not in a positive way. Today’s pharmaceutical products rely on ingredients and material from across the globe, and require the tightest, safest, and most efficient supply chain possible to produce the highest quality drugs.

Advertisement
X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading